Skip to content
healthcare.dev

Doxorubicin Hydrochloride

NDC 47335-050, Doxorubicin Hydrochloride, injectable, liposomal, from Sun Pharmaceutical Industries, Inc..

Product NDC
47335-050
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
INJECTABLE, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203263
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47335-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
47335-050-40473350050401 VIAL, SINGLE-DOSE in 1 PACKAGE (47335-050-40) / 25 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fbc48fa5-0bfb-4957-b13c-a56bb7a13b56
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=47335-050

Use it

Look up 47335-050 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47335-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47335-050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.